Biote Revenue Growth Rates (BTMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biote Corp   (NASDAQ: BTMD)
 

BTMD's Revenue Growth by Quarter and Year

Biote 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BTMD/growth
https://api.csimarket.com/api/v1/companies/BTMD/fundamentals
https://api.csimarket.com/api/v1/companies/BTMD/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
BTMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 43.33
2nd Quarter June 44.23
1st Quarter March 44.94
FY 132.50

BTMDs Annual Revenue
Biote 's Revenue in the fiscal year 2025 $ 192.22 millions
Biote 's Revenue in the fiscal year 2024 $ 197.19 millions
Biote 's Revenue in the fiscal year 2023 $ 185.36 millions
Biote 's Revenue in the fiscal year 2022 $ 164.96 millions
Biote 's Revenue in the fiscal year 2021 $ 139.40 millions




BTMD Revenue third quarter 2026 Y/Y Growth Comment
Biote Corp reported decrease in Revenue in the third quarter 2026 by -9.65% to $ 43.33 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Biote Corp 's Revenue compares unfavorably to the Company's average Revenue growth of 6.2%.

Looking into third quarter 2026 results within Legal Cannabis industry 17 other companies have achieved higher Revenue growth. While Biote Corp ' s Revenue decline of -9.65% ranks overall at the positon no. 3311 in the third quarter 2026.


BTMD Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -9.65 %
2nd Quarter June -9.48 %
1st Quarter March -8.27 %
FY   -

Financial Statements
Biote 's third quarter 2026 Revenue $ 43.33 millions BTMD's Income Statement
Biote 's third quarter 2025 Revenue $ 47.96 millions Quarterly BTMD's Income Statement


BTMD Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -2.03 %
2nd Quarter June -1.58 %
1st Quarter March -3.17 %
FY (Year on Year)   -


Back to BTMD Growth rate Comparisons >> Back to BTMD Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #18
Consumer Non Cyclical Sector #133
Overall #3311

Revenue Y/Y Growth Statistics
High Average Low
20.73 % 6.2 % -9.48 %
(Mar 31 2025)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #18
Consumer Non Cyclical Sector #133
Overall #3311
Revenue Y/Y Growth Statistics
High Average Low
20.73 % 6.2 % -9.48 %
(Mar 31 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Biote 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
11.35 % 1.16 % -7.51 %
(Jun 30 2022)  


BTMD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Biote Corp disclosed fall in Revenue from the second quarter by -2.03% to $ 43.33 millions, from $ 44.23 millions achived in the previous reporting period.

But that's not important problem, as Biote 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Biote 's Revenue growth quarter on quarter, overall rank is 2163.


Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #5
Consumer Non Cyclical Sector #68
Overall #2163
Revenue Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #5
Consumer Non Cyclical Sector #68
Overall #2163
Revenue Q/Q Growth Statistics
High Average Low
11.35 % 1.16 % -7.51 %
(Jun 30 2022)  


BTMD's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 Biote Corp disclosed fall in Revenue from the second quarter by -2.03% to $ 43.33 millions, from $ 44.23 millions achived in the previous reporting period.

But that's not important problem, as Biote 's Revenue generally seem to plunge in this quarter.

Within Legal Cannabis industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Biote 's Revenue growth quarter on quarter, overall rank is 2163.


Biote 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 183.53
Y / Y Revenue Growth (TTM) -7.81 %
Year on Year Revenue Growth Overall Ranking # 1927
Seqeuential Revenue Change (TTM) -2.46 %
Seq. Revenue Growth (TTM) Overall Ranking # 2475


Cumulative Revenue growth Comment
Biote 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.81% year on year, at Jun 30 2026 compare to the -5.63% decrease at Mar 31 2026. If the Biote 's fiscal year would end at Jun 30 2026, annual Revenue would be $184 millions.

In the Consumer Non Cyclical sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1927, from total ranking in previous quarter at 2187.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 12
Consumer Non Cyclical Sector # 61
Overall # 1927

Revenue TTM Y/Y Growth Statistics
High Average Low
19.1 %
 6.33 %
-7.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 90
S&P 500 # 2475
Cumulative Revenue growth Comment
Biote 's cumulative 12 months Revenue continue to decline, but on the faster rate at -7.81% year on year, at Jun 30 2026 compare to the -5.63% decrease at Mar 31 2026. If the Biote 's fiscal year would end at Jun 30 2026, annual Revenue would be $184 millions.

In the Consumer Non Cyclical sector 60 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1927, from total ranking in previous quarter at 2187.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry # 12
Consumer Non Cyclical Sector # 61
Overall # 1927

Revenue TTM Y/Y Growth Statistics
High Average Low
19.1 %
6.33 %
-7.81 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 90
S&P 500 # 2475




Other Revenue Growth
Legal Cannabis Industry Revenue Growth Trends and Statistics
Consumer Non Cyclical Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BTMD's Revenue Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Sep 30 2026 within Consumer Non Cyclical SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Ingredion Incorporated-1.32%$ -1.322 millions
Coty Inc -1.37%$ -1.370 millions
Tootsie Roll Industries Inc-1.44%$ -1.440 millions
Kraft Heinz Co-1.96%$ -1.956 millions
Utz Brands Inc -2.04%$ -2.043 millions
Pilgrim s Pride Corporation-2.21%$ -2.210 millions
The Marzetti Company-2.29%$ -2.292 millions
The Boston Beer Company Inc -3.24%$ -3.236 millions
Sanfilippo John B and Son Inc-3.53%$ -3.531 millions
Brightview Holdings Inc -3.71%$ -3.710 millions
Beyond Meat Inc -6.79%$ -6.790 millions
Vital Farms Inc -7.98%$ -7.980 millions
Smithfield Foods Inc -8.27%$ -8.273 millions
American Vanguard Corporation-9.09%$ -9.091 millions
Ispire Technology Inc-9.25%$ -9.253 millions
Mgp Ingredients Inc -9.60%$ -9.600 millions
Biote Corp -9.64%$ -9.638 millions
Mosaic Co-10.16%$ -10.161 millions
Cvr Partners Lp-10.64%$ -10.637 millions
Mannatech Inc-12.02%$ -12.023 millions
Westrock Coffee Company-15.29%$ -15.294 millions
Natural Health Trends Corp -15.88%$ -15.878 millions
Tofutti Brands Inc -18.76%$ -18.762 millions
Medifast Inc -19.19%$ -19.192 millions
Niagen Bioscience Inc -19.99%$ -19.991 millions
Trulieve Cannabis Corp.-20.12%$ -20.116 millions
The Hain Celestial Group Inc -29.25%$ -29.251 millions
Upexi Inc -62.29%$ -62.292 millions
CN Healthy Food Tech Group Corp.-68.91%$ -68.913 millions


About Biote Revenue Growth Rates (BTMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Biote Corp (CIK 1819253).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-453823
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Biote Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.